Articles From: Oxbridge Re to Attend Liolios Group 3rd Annual Gateway Conference and Participates in IPO Readiness Panel to P&F Industries, Inc. Acquires Exhaust Technologies, Inc.


Oxbridge Re Holdings Limited (NASDAQ: OXBR ), a provider of reinsurance solutions primarily to property and casualty insurers in the Gulf Coast region of the United States, has been invited to attend the 2014 Gateway Conference being held on Thursday, September 4, 2014 at The Palace Hotel in San Francisco.
Sign-up for Oxbridge Re to Attend Liolios Group 3rd Annual Gateway Conference and Participates in IPO Readiness Panel investment picks
COLUMBUS, Ohio , July 3, 2014 /PRNewswire/ -- Oxford Resource Partners, LP (NYSE: OXF) (the "Partnership" or "Oxford") announced today that the New York Stock Exchange (the "NYSE") has notified the Partnership that it has fallen below the NYSE's continued listing standard relating to the price of its common units, which requires a minimum average closing price of $1.00 per unit over any period of 30 consecutive trading days.
Sign-up for Oxford Addresses NYSE Continued Listing Standard investment picks
ATLANTA, June 19, 2014 (GLOBE NEWSWIRE) -- Oxford Industries, Inc. (NYSE:OXM) announced today that, on June 18, 2014, its Board of Directors declared a cash dividend of $0.21 per share on common stock payable on August 1, 2014 to shareholders of record as of the close of business on July 18, 2014.
Sign-up for Oxford Declares Quarterly Cash Dividend investment picks
Due to recent changes in the OTC Markets, Oxford Investments Holdings Inc. (OTCQB: OXIHF) has filed a Form 15 with the Securities and Exchange Commission (SEC) to voluntarily de-register from the SEC.
Sign-up for Oxford Files Form 15 investment picks
OXFORD, United Kingdom and MARLBOROUGH, Mass., Aug.
Sign-up for Oxford Immunotec Announces Purchase of Assets of Boulder Diagnostics Inc. investment picks
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 7, 2014 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) , a global, commercial-stage diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology, today announced that Louis O'Dea, MB, BCh, BAO, has joined the company as Chief Medical Officer.
Sign-up for Oxford Immunotec Appoints Louis O'Dea Chief Medical Officer investment picks
2014 Second Quarter Revenue of $11.8 Million Increased 16% Compared to Prior Year Net Loss was $6.2 Million for the Second Quarter Appointment of Louis O'Dea to Chief Medical Officer Purchased Assets of Boulder Diagnostics Inc. OXFORD, United Kingdom and MARLBOROUGH, Mass., Aug.
Sign-up for Oxford Immunotec Reports Second Quarter 2014 Financial Results investment picks
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 23, 2014 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) today announced that it plans to release second quarter 2014 financial results prior to market open on Tuesday, August 5, 2014.
Sign-up for Oxford Immunotec Schedules Second Quarter 2014 Earnings Release and Conference Call for August 5, 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1136937&ProfileId=051205&sourceType=1 GREENWICH, CT --
Sign-up for Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results as of June 30, 2014 investment picks
-- Top-Line Growth Driven by Lilly Pulitzer and Tommy Bahama --
Sign-up for Oxford Reports Second Quarter Results investment picks
COLUMBUS, Ohio , Aug.
Sign-up for Oxford Resource Partners, LP Reports Second Quarter 2014 Financial Results investment picks
COLUMBUS, Ohio , July 25, 2014 /PRNewswire/ -- Oxford Resource Partners, LP (NYSE: OXF) (the "Partnership" or "Oxford") will report its second quarter 2014 financial results before the market opens on Tuesday, August 5 , 2014.
Sign-up for Oxford Resource Partners, LP to Report Second Quarter 2014 Financial Results on August 5, 2014 investment picks
SOUTH SAN FRANCISCO, Calif., Aug.
Sign-up for OXiGENE Announces Presentation at the Rodman and Renshaw Conference on September 9 investment picks
SOUTH SAN FRANCISCO, Calif., July 23, 2014 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) , a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, will report second quarter 2014 results on Tuesday, August 5, 2014.
Sign-up for OXiGENE Announces Second Quarter 2014 Earnings Conference Call and Webcast investment picks
- Phase 2 Trial of Fosbretabulin in Gastrointestinal Neuroendocrine Tumors Planned - SOUTH SAN FRANCISCO, Calif., Aug.
Sign-up for OXiGENE Reports Second Quarter 2014 Financial Results investment picks
Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced a collaboration with Imperial College London to provide supplemental funding to support the accelerated enrollment and completion of the ongoing LeoPARDS Trial (Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis) awarded by the Efficacy and Mechanism Evaluation (EME) Programme and funded by the Medical Research Council (MRC) and managed by the National Institute for Health Research (NIHR) on behalf of the MRC-NIHR partnership.
Sign-up for Oxygen Biotherapeutics Announces Collaboration with Imperial College London to Accelerate Enrollment of LeoPARDS Trial investment picks
Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced financial results for the fiscal year ended April 30, 2014, and provided a corporate update.
Sign-up for Oxygen Biotherapeutics Announces Fiscal Year 2014 Financial Results investment picks
Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the Company, with unanimous approval from the Board of Directors, has elected to stop the current Phase IIb trial for its Oxycyte drug candidate and consider strategic alternatives for the program moving forward.
Sign-up for Oxygen Biotherapeutics Announces Halt of Oxycyte Phase IIb Traumatic Brain Injury Trial investment picks
Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that John Kelley, Chief Executive Officer, will present a company overview at the Wedbush 2014 Life Sciences Management Access Conference at Le Parker Meridien in New York on Wednesday, August 13, 2014, at 1:20 p.m. ET.
Sign-up for Oxygen Biotherapeutics to Present at Wedbush 2014 Life Sciences Management Access Conference investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G017346-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/6/23/11G017346/Turquoise_Hill_Logo-933122435869.jpg VANCOUVER, BC--(Marketwired - June 23, 2014) - Turquoise Hill Resources (NYSE: TRQ) (NASDAQ: TRQ) (TSX: TRQ) today announced that Oyu Tolgoi LLC has received an audit report from the Mongolian Tax Authority claiming unpaid taxes, penalties and disallowed entitlements associated with the initial development of the Oyu Tolgoi mine.
Sign-up for Oyu Tolgoi Receives Audit Report From Mongolian Tax Authority investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G019976-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/8/14/11G019976/Turquoise_Hill_Logo-933122435869.jpg VANCOUVER, BC--(Marketwired - August 14, 2014) - Turquoise Hill Resources (NYSE: TRQ) (NASDAQ: TRQ) (TSX: TRQ) today announced that Oyu Tolgoi has signed a Power Sector Cooperation Agreement (PSCA) with the Government of Mongolia for the exploration of a Tavan Tolgoi-based independent power producer.
Sign-up for Oyu Tolgoi Signs Power Sector Cooperation Agreement With Government of Mongolia investment picks
TONTITOWN, Ark., June 24, 2014 (GLOBE NEWSWIRE) -- P.A.M. Transportation Services, Inc. (Nasdaq:PTSI) today announced that it is set to join the broad-market Russell ® 3000 Index and the Russell Global Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 27, 2014, according to a preliminary list of additions posted on June 13, 2014, on www.russell.com/indexes .
Sign-up for P.A.M. Transportation Services Set to Join Russell Global and Russell 3000 Indexes investment picks
TONTITOWN, Ark., July 28, 2014 (GLOBE NEWSWIRE) -- P.A.M. Transportation Services, Inc. (Nasdaq:PTSI) today reported net income of $4,945,299, or diluted and basic earnings per share of $0.62 for the quarter ended June 30, 2014, and net income of $6,301,907, or diluted earnings per share of $0.78 ($0.79 basic) for the six month period then ended.
Sign-up for P.A.M. Transportation Services, Inc. Announces Results for the Second Quarter Ended June 30, 2014 investment picks
NEW YORK , Aug.
Sign-up for P.S. From Aeropostale Launches In Mexico investment picks
MELVILLE, N.Y. , Aug.
Sign-up for P&F Industries Reports Results For The Three And Six-Month Periods Ended June 30, 2014 investment picks
2014/7/23
MELVILLE, N.Y. , July 23, 2014 /PRNewswire/ -- P&F Industries, Inc. (NASDAQ GM: PFIN), plans to release its results for the three and six-month periods ended June 30, 2014 before the market opens on Tuesday, August 12 , 2014.
Sign-up for P&F Industries To Report Results For The Three And Six-Month Periods Ended June 30, 2014 investment picks
MELVILLE, N.Y. , Aug.
Sign-up for P&F Industries, Inc. Acquires Air Tool Service Company investment picks
MELVILLE, N.Y. , July 2, 2014 /PRNewswire/ -- P&F Industries, Inc. (NASDAQ: PFIN) today announced that effective July 1, 2014 , it acquired all of the outstanding equity interests of Exhaust Technologies, Inc. ("ETI") through a merger of a newly formed subsidiary of P&F with and into ETI.
Sign-up for P&F Industries, Inc. Acquires Exhaust Technologies, Inc. investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Oxbridge Re to Attend Liolios Group 3rd Annual Gateway Conference and Participates in IPO Readiness Panel to P&F Industries, Inc. Acquires Exhaust Technologies, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices